

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.58634255 |
| 2 | respiratory electron transport chain (GO:0022904) | 4.31743109 |
| 3 | DNA deamination (GO:0045006) | 4.28788761 |
| 4 | electron transport chain (GO:0022900) | 4.24969119 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.12664282 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 3.91464941 |
| 7 | respiratory chain complex IV assembly (GO:0008535) | 3.76803613 |
| 8 | protein neddylation (GO:0045116) | 3.67880001 |
| 9 | proteasome assembly (GO:0043248) | 3.63588061 |
| 10 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.62474648 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 3.54616436 |
| 12 | cytochrome complex assembly (GO:0017004) | 3.46326423 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.42518350 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.41777104 |
| 15 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.38293031 |
| 16 | cytidine metabolic process (GO:0046087) | 3.28533916 |
| 17 | cytidine catabolic process (GO:0006216) | 3.28533916 |
| 18 | cytidine deamination (GO:0009972) | 3.28533916 |
| 19 | viral transcription (GO:0019083) | 3.25616953 |
| 20 | termination of RNA polymerase III transcription (GO:0006386) | 3.23910701 |
| 21 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.23910701 |
| 22 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23718611 |
| 23 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.21487143 |
| 24 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.20359576 |
| 25 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.20359576 |
| 26 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.20057125 |
| 27 | sequestering of actin monomers (GO:0042989) | 3.18945999 |
| 28 | regulation of cellular amine metabolic process (GO:0033238) | 3.15985047 |
| 29 | protein targeting to mitochondrion (GO:0006626) | 3.14377654 |
| 30 | cotranslational protein targeting to membrane (GO:0006613) | 3.13745661 |
| 31 | deoxyribose phosphate catabolic process (GO:0046386) | 3.10700501 |
| 32 | oxidative phosphorylation (GO:0006119) | 3.09852167 |
| 33 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.08934408 |
| 34 | translational termination (GO:0006415) | 3.08343367 |
| 35 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.05838278 |
| 36 | ATP synthesis coupled proton transport (GO:0015986) | 3.05838278 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05684759 |
| 38 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.05280582 |
| 39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.04480649 |
| 40 | protein targeting to ER (GO:0045047) | 3.03812446 |
| 41 | protein localization to mitochondrion (GO:0070585) | 3.01872231 |
| 42 | regulation of mitochondrial translation (GO:0070129) | 3.01776633 |
| 43 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.01181824 |
| 44 | 7-methylguanosine mRNA capping (GO:0006370) | 3.00906400 |
| 45 | positive regulation of cell cycle arrest (GO:0071158) | 3.00610361 |
| 46 | regulation of ligase activity (GO:0051340) | 3.00215374 |
| 47 | 7-methylguanosine RNA capping (GO:0009452) | 2.99787204 |
| 48 | RNA capping (GO:0036260) | 2.99787204 |
| 49 | deoxyribonucleotide catabolic process (GO:0009264) | 2.98639148 |
| 50 | purine nucleotide salvage (GO:0032261) | 2.97651708 |
| 51 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.95755150 |
| 52 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.95755150 |
| 53 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.95123166 |
| 54 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.95123166 |
| 55 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.95123166 |
| 56 | purine-containing compound salvage (GO:0043101) | 2.94038757 |
| 57 | negative regulation of ligase activity (GO:0051352) | 2.92273846 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.92273846 |
| 59 | establishment of protein localization to mitochondrion (GO:0072655) | 2.92047342 |
| 60 | rRNA modification (GO:0000154) | 2.91247609 |
| 61 | protein maturation by protein folding (GO:0022417) | 2.91131778 |
| 62 | maturation of SSU-rRNA (GO:0030490) | 2.90550972 |
| 63 | protein localization to endoplasmic reticulum (GO:0070972) | 2.90370599 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90334857 |
| 65 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.89633957 |
| 66 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.89598772 |
| 67 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.89162446 |
| 68 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.87911438 |
| 69 | hydrogen ion transmembrane transport (GO:1902600) | 2.87861701 |
| 70 | deoxyribose phosphate metabolic process (GO:0019692) | 2.87177367 |
| 71 | negative regulation of protein ubiquitination (GO:0031397) | 2.87044974 |
| 72 | microglial cell activation (GO:0001774) | 2.86655295 |
| 73 | ATP biosynthetic process (GO:0006754) | 2.86169688 |
| 74 | inner mitochondrial membrane organization (GO:0007007) | 2.85525090 |
| 75 | CENP-A containing nucleosome assembly (GO:0034080) | 2.85287309 |
| 76 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.84521046 |
| 77 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84131256 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83530738 |
| 79 | chaperone-mediated protein transport (GO:0072321) | 2.83192439 |
| 80 | positive regulation of protein homodimerization activity (GO:0090073) | 2.82688198 |
| 81 | signal peptide processing (GO:0006465) | 2.80506948 |
| 82 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.80304420 |
| 83 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.78696798 |
| 84 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.78549742 |
| 85 | response to pheromone (GO:0019236) | 2.78382499 |
| 86 | histone mRNA metabolic process (GO:0008334) | 2.77847999 |
| 87 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.77130245 |
| 88 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.76935730 |
| 89 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.76935730 |
| 90 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76628748 |
| 91 | ribosomal large subunit biogenesis (GO:0042273) | 2.76370661 |
| 92 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.74844082 |
| 93 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.74723415 |
| 94 | NADH dehydrogenase complex assembly (GO:0010257) | 2.74723415 |
| 95 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.74723415 |
| 96 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.72950750 |
| 97 | neutrophil activation (GO:0042119) | 2.70127078 |
| 98 | positive regulation of chemokine secretion (GO:0090197) | 2.69812369 |
| 99 | leukocyte aggregation (GO:0070486) | 2.69278556 |
| 100 | deoxyribonucleotide metabolic process (GO:0009262) | 2.69137560 |
| 101 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.68593741 |
| 102 | respiratory burst (GO:0045730) | 2.67739230 |
| 103 | protein K11-linked ubiquitination (GO:0070979) | 2.67730564 |
| 104 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66518046 |
| 105 | proton transport (GO:0015992) | 2.66230300 |
| 106 | peptidyl-histidine modification (GO:0018202) | 2.66106787 |
| 107 | chromatin remodeling at centromere (GO:0031055) | 2.65848646 |
| 108 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.65007368 |
| 109 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.64978198 |
| 110 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.64177098 |
| 111 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.63961603 |
| 112 | cellular response to interferon-beta (GO:0035458) | 2.60291909 |
| 113 | mast cell activation (GO:0045576) | 2.58768570 |
| 114 | viral life cycle (GO:0019058) | 2.58584612 |
| 115 | protein complex biogenesis (GO:0070271) | 2.58482490 |
| 116 | establishment of viral latency (GO:0019043) | 2.56128228 |
| 117 | translational elongation (GO:0006414) | 2.55307361 |
| 118 | interferon-gamma production (GO:0032609) | 2.54102506 |
| 119 | mannosylation (GO:0097502) | 2.53512103 |
| 120 | platelet dense granule organization (GO:0060155) | 2.52762021 |
| 121 | DNA damage response, detection of DNA damage (GO:0042769) | 2.52740956 |
| 122 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.52478722 |
| 123 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.49978029 |
| 124 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.49038963 |
| 125 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.45958155 |
| 126 | regulation of T cell migration (GO:2000404) | 2.44214874 |
| 127 | GPI anchor biosynthetic process (GO:0006506) | 2.42740240 |
| 128 | cellular protein complex disassembly (GO:0043624) | 2.42722391 |
| 129 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.42551619 |
| 130 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.42551619 |
| 131 | positive regulation of T cell migration (GO:2000406) | 2.41832624 |
| 132 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.41795541 |
| 133 | regulation of antigen processing and presentation (GO:0002577) | 2.40751823 |
| 134 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.40693437 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39949156 |
| 136 | granulocyte activation (GO:0036230) | 2.39055043 |
| 137 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.37443643 |
| 138 | positive regulation of interleukin-10 production (GO:0032733) | 2.37374737 |
| 139 | organelle disassembly (GO:1903008) | 2.37072167 |
| 140 | protein deneddylation (GO:0000338) | 2.36742916 |
| 141 | translation (GO:0006412) | 2.36114497 |
| 142 | cullin deneddylation (GO:0010388) | 2.35377769 |
| 143 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.35073490 |
| 144 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.34904712 |
| 145 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.34776700 |
| 146 | GTP biosynthetic process (GO:0006183) | 2.32185136 |
| 147 | histamine secretion (GO:0001821) | 2.31605721 |
| 148 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.31603176 |
| 149 | positive regulation of ligase activity (GO:0051351) | 2.31263844 |
| 150 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.30026664 |
| 151 | lymphoid progenitor cell differentiation (GO:0002320) | 2.29496581 |
| 152 | oligosaccharide catabolic process (GO:0009313) | 2.29188671 |
| 153 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.28328454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.40844292 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.03165645 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81515958 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.73812038 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.39311882 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.37050565 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22197470 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16075319 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15266622 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.13136080 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.89590850 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.77683001 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77509053 |
| 14 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.63129818 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.59176094 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56075135 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.52424733 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52154212 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.46012648 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.34889123 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.31577552 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.27316641 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.26027351 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14131853 |
| 25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14055744 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05788892 |
| 27 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.03082065 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96794569 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.96367479 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.91747209 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86883987 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.77106051 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72138726 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71700105 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68211527 |
| 36 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65479489 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65388754 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.60623376 |
| 39 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.60105214 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.59720690 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51386312 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48499547 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46413740 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46017155 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42576697 |
| 46 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42490110 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.41312827 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41257018 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41031481 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38072171 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37992484 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36783069 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36433805 |
| 54 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34264454 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33256018 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31268034 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30251277 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30176563 |
| 59 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29883940 |
| 60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.29718199 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26842780 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26732554 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24941901 |
| 64 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24176185 |
| 65 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23150551 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21946421 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19209485 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19039035 |
| 69 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17253144 |
| 70 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16073637 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14918124 |
| 72 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11380208 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10366170 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10299502 |
| 75 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.09830309 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08393289 |
| 77 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08223570 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07440946 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05322497 |
| 80 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05260645 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05178674 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03726431 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02788374 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02575981 |
| 85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02554827 |
| 86 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.01704024 |
| 87 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00920278 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00602201 |
| 89 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99337651 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98995200 |
| 91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98474096 |
| 92 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98474096 |
| 93 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98438333 |
| 94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98416758 |
| 95 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97179691 |
| 96 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.96520352 |
| 97 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96313008 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95937070 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94985085 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94168289 |
| 101 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93802933 |
| 102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93721975 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93367263 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 0.91986769 |
| 105 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91560428 |
| 106 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91560428 |
| 107 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91161687 |
| 108 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90654879 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90571104 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90532041 |
| 111 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89377741 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87971146 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87280441 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87198684 |
| 115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86952695 |
| 116 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.86744151 |
| 117 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86459856 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86414208 |
| 119 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.85989705 |
| 120 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.85890117 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.85811003 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85019008 |
| 123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84925743 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84637864 |
| 125 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83983497 |
| 126 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83227280 |
| 127 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82828652 |
| 128 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.82413966 |
| 129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.80144739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.39031917 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.96100586 |
| 3 | MP0005671_abnormal_response_to | 3.23118392 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.87501915 |
| 5 | MP0009379_abnormal_foot_pigmentation | 2.75840944 |
| 6 | MP0003136_yellow_coat_color | 2.75636941 |
| 7 | MP0006082_CNS_inflammation | 2.72534328 |
| 8 | MP0009785_altered_susceptibility_to | 2.72375537 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.66935097 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.61961746 |
| 11 | MP0001529_abnormal_vocalization | 2.59168739 |
| 12 | MP0005409_darkened_coat_color | 2.54435869 |
| 13 | MP0003880_abnormal_central_pattern | 2.46391746 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.40553317 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.38288656 |
| 16 | MP0004381_abnormal_hair_follicle | 2.36269384 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.14111097 |
| 18 | MP0003724_increased_susceptibility_to | 2.13099921 |
| 19 | MP0005025_abnormal_response_to | 2.11040167 |
| 20 | MP0002723_abnormal_immune_serum | 2.07235267 |
| 21 | MP0002419_abnormal_innate_immunity | 2.06907623 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.06872740 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.06021660 |
| 24 | MP0001819_abnormal_immune_cell | 2.05594664 |
| 25 | MP0001800_abnormal_humoral_immune | 2.04711286 |
| 26 | MP0005387_immune_system_phenotype | 2.04072902 |
| 27 | MP0001790_abnormal_immune_system | 2.04072902 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.99907739 |
| 29 | MP0001188_hyperpigmentation | 1.96849697 |
| 30 | MP0006072_abnormal_retinal_apoptosis | 1.92840286 |
| 31 | MP0003718_maternal_effect | 1.91641961 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.91269325 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.90411399 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.89252035 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.81979432 |
| 36 | MP0000685_abnormal_immune_system | 1.72552075 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.71483398 |
| 38 | MP0002163_abnormal_gland_morphology | 1.66912627 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.65934820 |
| 40 | MP0000920_abnormal_myelination | 1.65227642 |
| 41 | MP0005171_absent_coat_pigmentation | 1.63276506 |
| 42 | MP0001905_abnormal_dopamine_level | 1.62653633 |
| 43 | MP0003436_decreased_susceptibility_to | 1.62201094 |
| 44 | MP0002398_abnormal_bone_marrow | 1.56349547 |
| 45 | MP0002132_abnormal_respiratory_system | 1.53996698 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.53364263 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.53063842 |
| 48 | MP0000716_abnormal_immune_system | 1.52631197 |
| 49 | MP0001764_abnormal_homeostasis | 1.51086688 |
| 50 | MP0003195_calcinosis | 1.49042961 |
| 51 | MP0000358_abnormal_cell_content/ | 1.46590127 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.45197523 |
| 53 | MP0001853_heart_inflammation | 1.44689322 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.41925501 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.40365699 |
| 56 | MP0002405_respiratory_system_inflammati | 1.38591905 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.36820690 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.33693667 |
| 59 | MP0002090_abnormal_vision | 1.30479328 |
| 60 | MP0002009_preneoplasia | 1.30389434 |
| 61 | MP0002006_tumorigenesis | 1.30360664 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.30283123 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.27515374 |
| 64 | MP0006054_spinal_hemorrhage | 1.26428137 |
| 65 | MP0005253_abnormal_eye_physiology | 1.22710841 |
| 66 | MP0008058_abnormal_DNA_repair | 1.21200649 |
| 67 | MP0002429_abnormal_blood_cell | 1.20832315 |
| 68 | MP0002722_abnormal_immune_system | 1.20787866 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.19560978 |
| 70 | MP0008007_abnormal_cellular_replicative | 1.19487656 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.18617660 |
| 72 | MP0005332_abnormal_amino_acid | 1.17955272 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.12495784 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.09869037 |
| 75 | MP0008057_abnormal_DNA_replication | 1.08715187 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.08336818 |
| 77 | MP0001851_eye_inflammation | 1.08218225 |
| 78 | MP0006292_abnormal_olfactory_placode | 1.06039406 |
| 79 | MP0002876_abnormal_thyroid_physiology | 1.05329011 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 1.05277780 |
| 81 | MP0001845_abnormal_inflammatory_respons | 1.04555807 |
| 82 | MP0004147_increased_porphyrin_level | 1.04367730 |
| 83 | MP0003011_delayed_dark_adaptation | 1.00516509 |
| 84 | MP0003252_abnormal_bile_duct | 0.99580613 |
| 85 | MP0004142_abnormal_muscle_tone | 0.99409552 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.97754581 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.97585240 |
| 88 | MP0005310_abnormal_salivary_gland | 0.97504378 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.96440358 |
| 90 | MP0002933_joint_inflammation | 0.95001052 |
| 91 | MP0003448_altered_tumor_morphology | 0.94710417 |
| 92 | MP0001542_abnormal_bone_strength | 0.94432501 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.93623089 |
| 94 | MP0002938_white_spotting | 0.93374074 |
| 95 | MP0005389_reproductive_system_phenotype | 0.91451071 |
| 96 | MP0000343_altered_response_to | 0.89629855 |
| 97 | MP0009697_abnormal_copulation | 0.89616832 |
| 98 | MP0002160_abnormal_reproductive_system | 0.89175260 |
| 99 | MP0003186_abnormal_redox_activity | 0.87751681 |
| 100 | MP0003866_abnormal_defecation | 0.87345013 |
| 101 | MP0005408_hypopigmentation | 0.87289235 |
| 102 | MP0003786_premature_aging | 0.87015078 |
| 103 | MP0008260_abnormal_autophagy | 0.86105306 |
| 104 | MP0008872_abnormal_physiological_respon | 0.86097794 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.85102594 |
| 106 | MP0009764_decreased_sensitivity_to | 0.84968856 |
| 107 | MP0002736_abnormal_nociception_after | 0.84380221 |
| 108 | MP0000371_diluted_coat_color | 0.80821489 |
| 109 | MP0000516_abnormal_urinary_system | 0.80343084 |
| 110 | MP0005367_renal/urinary_system_phenotyp | 0.80343084 |
| 111 | MP0003787_abnormal_imprinting | 0.79769830 |
| 112 | MP0002102_abnormal_ear_morphology | 0.79723982 |
| 113 | MP0004510_myositis | 0.78982274 |
| 114 | MP0009046_muscle_twitch | 0.78321346 |
| 115 | MP0008873_increased_physiological_sensi | 0.77929371 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.77704357 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.76918123 |
| 118 | MP0001756_abnormal_urination | 0.76856034 |
| 119 | MP0003122_maternal_imprinting | 0.76674026 |
| 120 | MP0005410_abnormal_fertilization | 0.75941175 |
| 121 | MP0008469_abnormal_protein_level | 0.75837639 |
| 122 | MP0001984_abnormal_olfaction | 0.75092913 |
| 123 | MP0001986_abnormal_taste_sensitivity | 0.74694418 |
| 124 | MP0006276_abnormal_autonomic_nervous | 0.74610962 |
| 125 | MP0003828_pulmonary_edema | 0.74417127 |
| 126 | MP0003077_abnormal_cell_cycle | 0.73692050 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.73539891 |
| 128 | MP0003121_genomic_imprinting | 0.72037093 |
| 129 | MP0010094_abnormal_chromosome_stability | 0.71893253 |
| 130 | MP0004215_abnormal_myocardial_fiber | 0.70103017 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.70066381 |
| 132 | MP0001119_abnormal_female_reproductive | 0.69967280 |
| 133 | MP0000858_altered_metastatic_potential | 0.69952726 |
| 134 | MP0005395_other_phenotype | 0.69595234 |
| 135 | MP0001929_abnormal_gametogenesis | 0.68944740 |
| 136 | MP0009763_increased_sensitivity_to | 0.68486071 |
| 137 | MP0003690_abnormal_glial_cell | 0.67625041 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.66639293 |
| 139 | MP0001186_pigmentation_phenotype | 0.66212613 |
| 140 | MP0000778_abnormal_nervous_system | 0.65700365 |
| 141 | MP0004742_abnormal_vestibular_system | 0.65278525 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.65158518 |
| 143 | MP0001968_abnormal_touch/_nociception | 0.65138408 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.61829229 |
| 145 | MP0002751_abnormal_autonomic_nervous | 0.61232408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 3.96380774 |
| 2 | 3-Methylglutaconic aciduria (HP:0003535) | 3.79890260 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.62966260 |
| 4 | Cerebral edema (HP:0002181) | 3.50350060 |
| 5 | Aplastic anemia (HP:0001915) | 3.42998535 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.28599443 |
| 7 | Mitochondrial inheritance (HP:0001427) | 3.27289122 |
| 8 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.16924247 |
| 9 | Progressive macrocephaly (HP:0004481) | 3.15714044 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.13661512 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.11717861 |
| 12 | Lactic acidosis (HP:0003128) | 3.11053331 |
| 13 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.03204460 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 3.03204460 |
| 15 | Hyperalaninemia (HP:0003348) | 3.03204460 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01826067 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99643480 |
| 18 | Optic neuritis (HP:0100653) | 2.99404997 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 2.99404997 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99343604 |
| 21 | Parakeratosis (HP:0001036) | 2.98214811 |
| 22 | Renal Fanconi syndrome (HP:0001994) | 2.95408279 |
| 23 | Increased intramyocellular lipid droplets (HP:0012240) | 2.94211806 |
| 24 | Stomatitis (HP:0010280) | 2.91922629 |
| 25 | Increased CSF lactate (HP:0002490) | 2.76272677 |
| 26 | Hepatocellular necrosis (HP:0001404) | 2.75999584 |
| 27 | Increased IgM level (HP:0003496) | 2.75882605 |
| 28 | Myositis (HP:0100614) | 2.74108385 |
| 29 | Reticulocytopenia (HP:0001896) | 2.68094653 |
| 30 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.67553409 |
| 31 | Obstructive lung disease (HP:0006536) | 2.67163684 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67163684 |
| 33 | Thyroiditis (HP:0100646) | 2.64736485 |
| 34 | Microvesicular hepatic steatosis (HP:0001414) | 2.60865124 |
| 35 | Exertional dyspnea (HP:0002875) | 2.59472011 |
| 36 | Birth length less than 3rd percentile (HP:0003561) | 2.59305176 |
| 37 | Abnormality of glycolysis (HP:0004366) | 2.58068638 |
| 38 | Increased serum pyruvate (HP:0003542) | 2.58068638 |
| 39 | Renal cortical cysts (HP:0000803) | 2.55858370 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.55073564 |
| 41 | Methylmalonic acidemia (HP:0002912) | 2.54778445 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.52359524 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.52359524 |
| 44 | Patchy hypopigmentation of hair (HP:0011365) | 2.51273905 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.49234795 |
| 46 | IgG deficiency (HP:0004315) | 2.47464245 |
| 47 | Acute encephalopathy (HP:0006846) | 2.46136557 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.44747706 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.44466764 |
| 50 | Abnormal hair whorl (HP:0010721) | 2.42726869 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.41282874 |
| 52 | Orchitis (HP:0100796) | 2.40099459 |
| 53 | Degeneration of anterior horn cells (HP:0002398) | 2.39589183 |
| 54 | Abnormality of the anterior horn cell (HP:0006802) | 2.39589183 |
| 55 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.38639214 |
| 56 | Abnormal protein glycosylation (HP:0012346) | 2.38639214 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.38636336 |
| 58 | Increased muscle lipid content (HP:0009058) | 2.36775376 |
| 59 | Agnosia (HP:0010524) | 2.36630319 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36356626 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36356626 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.35295317 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.32992522 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.31745808 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.31706248 |
| 66 | IgM deficiency (HP:0002850) | 2.31527626 |
| 67 | Lipid accumulation in hepatocytes (HP:0006561) | 2.31325551 |
| 68 | Recurrent skin infections (HP:0001581) | 2.31271149 |
| 69 | Hypothermia (HP:0002045) | 2.28753817 |
| 70 | Type I transferrin isoform profile (HP:0003642) | 2.28584429 |
| 71 | Lethargy (HP:0001254) | 2.27187368 |
| 72 | Agammaglobulinemia (HP:0004432) | 2.27128081 |
| 73 | Hypoproteinemia (HP:0003075) | 2.23811244 |
| 74 | Glycosuria (HP:0003076) | 2.23599119 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.23599119 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23220076 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22979397 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.22052630 |
| 79 | Increased serum lactate (HP:0002151) | 2.21089640 |
| 80 | T lymphocytopenia (HP:0005403) | 2.18665199 |
| 81 | Macrocytic anemia (HP:0001972) | 2.18057160 |
| 82 | Abnormality of T cell physiology (HP:0011840) | 2.15333785 |
| 83 | Abnormality of midbrain morphology (HP:0002418) | 2.14250756 |
| 84 | Molar tooth sign on MRI (HP:0002419) | 2.14250756 |
| 85 | CNS demyelination (HP:0007305) | 2.13393732 |
| 86 | Abnormality of the prostate (HP:0008775) | 2.13303027 |
| 87 | Recurrent pneumonia (HP:0006532) | 2.12794787 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.11495289 |
| 89 | Abnormality of the axillary hair (HP:0100134) | 2.11398238 |
| 90 | Abnormality of secondary sexual hair (HP:0009888) | 2.11398238 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.06931903 |
| 92 | Hepatic necrosis (HP:0002605) | 2.05735482 |
| 93 | White forelock (HP:0002211) | 2.05454764 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.03545460 |
| 95 | Palpitations (HP:0001962) | 2.00114383 |
| 96 | Chronic diarrhea (HP:0002028) | 1.97421813 |
| 97 | Pallor (HP:0000980) | 1.97097274 |
| 98 | Meningitis (HP:0001287) | 1.96676651 |
| 99 | Prostate neoplasm (HP:0100787) | 1.96135904 |
| 100 | Medial flaring of the eyebrow (HP:0010747) | 1.95860054 |
| 101 | Encephalitis (HP:0002383) | 1.94568695 |
| 102 | Constricted visual fields (HP:0001133) | 1.93904191 |
| 103 | Poor head control (HP:0002421) | 1.93762921 |
| 104 | Respiratory failure (HP:0002878) | 1.93599934 |
| 105 | Pancreatic cysts (HP:0001737) | 1.93145198 |
| 106 | Chronic otitis media (HP:0000389) | 1.92232854 |
| 107 | Abnormality of serum amino acid levels (HP:0003112) | 1.91818901 |
| 108 | Leukodystrophy (HP:0002415) | 1.91774987 |
| 109 | Respiratory difficulties (HP:0002880) | 1.91573048 |
| 110 | Pancytopenia (HP:0001876) | 1.91171219 |
| 111 | Optic disc pallor (HP:0000543) | 1.91104825 |
| 112 | Abnormality of renal resorption (HP:0011038) | 1.90779706 |
| 113 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.90412929 |
| 114 | Exercise intolerance (HP:0003546) | 1.90393354 |
| 115 | Anhidrosis (HP:0000970) | 1.90141632 |
| 116 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.90102246 |
| 117 | B lymphocytopenia (HP:0010976) | 1.89987636 |
| 118 | Basal ganglia calcification (HP:0002135) | 1.89825658 |
| 119 | Type 2 muscle fiber atrophy (HP:0003554) | 1.87898891 |
| 120 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87326195 |
| 121 | Recurrent bronchitis (HP:0002837) | 1.86014506 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.85225153 |
| 123 | Eosinophilia (HP:0001880) | 1.85062577 |
| 124 | Heterochromia iridis (HP:0001100) | 1.84240432 |
| 125 | X-linked dominant inheritance (HP:0001423) | 1.84101340 |
| 126 | Abnormality of T cells (HP:0002843) | 1.83512828 |
| 127 | Vasculitis (HP:0002633) | 1.83194051 |
| 128 | Abnormality of the renal cortex (HP:0011035) | 1.83078124 |
| 129 | Median cleft lip (HP:0000161) | 1.82167769 |
| 130 | Leukocytosis (HP:0001974) | 1.81838459 |
| 131 | Abnormality of B cell number (HP:0010975) | 1.81788068 |
| 132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.81590912 |
| 133 | Abnormality of placental membranes (HP:0011409) | 1.80662615 |
| 134 | Amniotic constriction ring (HP:0009775) | 1.80662615 |
| 135 | Panhypogammaglobulinemia (HP:0003139) | 1.80184262 |
| 136 | Neutropenia (HP:0001875) | 1.79920344 |
| 137 | Nausea (HP:0002018) | 1.79849050 |
| 138 | Oral leukoplakia (HP:0002745) | 1.79137252 |
| 139 | Combined immunodeficiency (HP:0005387) | 1.78901803 |
| 140 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76726849 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.75279379 |
| 142 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75279379 |
| 143 | Recurrent fungal infections (HP:0002841) | 1.75125376 |
| 144 | Pancreatic fibrosis (HP:0100732) | 1.74387968 |
| 145 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74360518 |
| 146 | Keratoconjunctivitis (HP:0001096) | 1.74079197 |
| 147 | Microretrognathia (HP:0000308) | 1.74005655 |
| 148 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73188696 |
| 149 | Posterior subcapsular cataract (HP:0007787) | 1.72826440 |
| 150 | Prolonged neonatal jaundice (HP:0006579) | 1.72350060 |
| 151 | Congenital, generalized hypertrichosis (HP:0004540) | 1.71942499 |
| 152 | Testicular atrophy (HP:0000029) | 1.70970340 |
| 153 | Autoimmune thrombocytopenia (HP:0001973) | 1.70487661 |
| 154 | Reduced antithrombin III activity (HP:0001976) | 1.68063897 |
| 155 | Sparse eyelashes (HP:0000653) | 1.67651108 |
| 156 | Hypoplasia of the uterus (HP:0000013) | 1.67635626 |
| 157 | Hypoplasia of the fovea (HP:0007750) | 1.66818677 |
| 158 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.66818677 |
| 159 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.66566265 |
| 160 | Abnormal glycosylation (HP:0012345) | 1.66566265 |
| 161 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.66093359 |
| 162 | Dyschromatopsia (HP:0007641) | 1.64591273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 2.96183964 |
| 2 | VRK1 | 2.81375232 |
| 3 | TXK | 2.80606959 |
| 4 | IRAK4 | 2.56193617 |
| 5 | TRIM28 | 2.54057645 |
| 6 | MAP3K12 | 2.41196585 |
| 7 | MST4 | 2.38510636 |
| 8 | STK16 | 2.31223685 |
| 9 | NEK1 | 2.25161706 |
| 10 | EIF2AK3 | 2.23457077 |
| 11 | VRK2 | 2.16424339 |
| 12 | BCR | 2.11060827 |
| 13 | PBK | 2.09118405 |
| 14 | EIF2AK1 | 2.03830663 |
| 15 | ADRBK2 | 1.95473848 |
| 16 | BLK | 1.95054853 |
| 17 | BMPR1B | 1.94168123 |
| 18 | NME2 | 1.88650062 |
| 19 | SCYL2 | 1.87388077 |
| 20 | MAP3K14 | 1.85905999 |
| 21 | MAP4K2 | 1.81290962 |
| 22 | BUB1 | 1.78119732 |
| 23 | TNIK | 1.67836120 |
| 24 | SIK3 | 1.62377253 |
| 25 | ACVR1B | 1.53972051 |
| 26 | TEC | 1.49280616 |
| 27 | GRK7 | 1.46305809 |
| 28 | KIT | 1.44490281 |
| 29 | TLK1 | 1.44168576 |
| 30 | BCKDK | 1.39584861 |
| 31 | IKBKE | 1.37113501 |
| 32 | BMPR2 | 1.33331449 |
| 33 | MAP4K1 | 1.31332111 |
| 34 | ZAK | 1.30743329 |
| 35 | SRPK1 | 1.29692581 |
| 36 | IRAK3 | 1.24428214 |
| 37 | GRK1 | 1.23669046 |
| 38 | CLK1 | 1.23137481 |
| 39 | YES1 | 1.16826833 |
| 40 | NUAK1 | 1.14538592 |
| 41 | NEK9 | 1.13744902 |
| 42 | TAOK3 | 1.12902763 |
| 43 | BRSK2 | 1.12845524 |
| 44 | IKBKB | 1.11799463 |
| 45 | MKNK1 | 1.10477762 |
| 46 | ITK | 1.08359576 |
| 47 | LYN | 1.08155170 |
| 48 | SYK | 1.07732364 |
| 49 | ERBB3 | 1.05586186 |
| 50 | ZAP70 | 1.04895511 |
| 51 | PDK2 | 1.04622793 |
| 52 | EIF2AK2 | 1.04428696 |
| 53 | TYK2 | 1.03802658 |
| 54 | OXSR1 | 1.03129373 |
| 55 | LCK | 1.01454876 |
| 56 | PLK3 | 0.99210006 |
| 57 | TGFBR2 | 0.97990362 |
| 58 | TESK2 | 0.97001254 |
| 59 | PLK2 | 0.96350421 |
| 60 | RIPK4 | 0.94776168 |
| 61 | DYRK2 | 0.90917129 |
| 62 | BTK | 0.89005789 |
| 63 | TBK1 | 0.88687517 |
| 64 | TESK1 | 0.86079640 |
| 65 | DAPK1 | 0.85181798 |
| 66 | MAPKAPK5 | 0.84459667 |
| 67 | CSNK1G3 | 0.83282451 |
| 68 | WNK3 | 0.82559771 |
| 69 | PKN1 | 0.80929045 |
| 70 | IRAK2 | 0.80812261 |
| 71 | MAP2K7 | 0.79733535 |
| 72 | FLT3 | 0.79652798 |
| 73 | TGFBR1 | 0.79286739 |
| 74 | RPS6KA4 | 0.78784844 |
| 75 | NME1 | 0.78380671 |
| 76 | KDR | 0.77967289 |
| 77 | LIMK1 | 0.75818665 |
| 78 | FGR | 0.75507266 |
| 79 | STK24 | 0.75458626 |
| 80 | PAK4 | 0.74830693 |
| 81 | PIM2 | 0.74794120 |
| 82 | CDK19 | 0.74163413 |
| 83 | TSSK6 | 0.74046627 |
| 84 | CDK3 | 0.73051410 |
| 85 | PLK1 | 0.71671626 |
| 86 | RPS6KA5 | 0.71404401 |
| 87 | FES | 0.70158083 |
| 88 | STK3 | 0.69924967 |
| 89 | ILK | 0.69616773 |
| 90 | MAPK13 | 0.69504745 |
| 91 | CSF1R | 0.69178547 |
| 92 | STK39 | 0.68043175 |
| 93 | EPHA3 | 0.65080334 |
| 94 | NEK6 | 0.63865028 |
| 95 | STK10 | 0.63692716 |
| 96 | PRPF4B | 0.63590081 |
| 97 | TRPM7 | 0.62018205 |
| 98 | CDK8 | 0.60189462 |
| 99 | MYLK | 0.57852467 |
| 100 | WEE1 | 0.56659031 |
| 101 | AURKB | 0.56471579 |
| 102 | CSNK1G1 | 0.55697482 |
| 103 | FGFR2 | 0.55463909 |
| 104 | JAK3 | 0.54923886 |
| 105 | CSNK1A1L | 0.54354045 |
| 106 | ABL2 | 0.54134978 |
| 107 | PNCK | 0.52622936 |
| 108 | PRKCQ | 0.52447309 |
| 109 | EPHA4 | 0.52249282 |
| 110 | TTK | 0.51935174 |
| 111 | PIK3CG | 0.50757457 |
| 112 | PLK4 | 0.50354418 |
| 113 | STK38L | 0.49787578 |
| 114 | STK4 | 0.49217654 |
| 115 | HCK | 0.48952028 |
| 116 | CSNK2A2 | 0.48762584 |
| 117 | ARAF | 0.48708052 |
| 118 | ADRBK1 | 0.47874392 |
| 119 | PRKCD | 0.46078613 |
| 120 | DAPK3 | 0.45999299 |
| 121 | CCNB1 | 0.45613034 |
| 122 | PINK1 | 0.44475556 |
| 123 | PAK3 | 0.44179618 |
| 124 | MAP3K5 | 0.43764742 |
| 125 | MUSK | 0.43577917 |
| 126 | CAMKK2 | 0.43577022 |
| 127 | PASK | 0.41588868 |
| 128 | CSNK2A1 | 0.41054533 |
| 129 | CSNK1G2 | 0.40985376 |
| 130 | ERBB4 | 0.40756887 |
| 131 | INSRR | 0.39573055 |
| 132 | UHMK1 | 0.39045304 |
| 133 | CSK | 0.38950025 |
| 134 | FRK | 0.38586416 |
| 135 | GRK5 | 0.38073084 |
| 136 | ABL1 | 0.37322534 |
| 137 | PRKCE | 0.37290502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.83940834 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.43926919 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.81909027 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.73593352 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.68301847 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34412698 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.23858062 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07643838 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01671577 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.88717837 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.73301264 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 1.68621866 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 1.68351311 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66487787 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.62916720 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62828964 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57058365 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.55962233 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.54635799 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51914283 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51382722 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.50060156 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45376391 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39771822 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.39544966 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37744685 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.37515146 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36073373 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32317305 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32014358 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31152315 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30413346 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.27744402 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27499214 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.25657679 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21633211 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19037936 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.18215019 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17946443 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16946327 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16102144 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15167009 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.12251967 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10224926 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.09462021 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.07506830 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06287840 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05783564 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.05744525 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.00160469 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.98978230 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.97240887 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93656026 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92195236 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91067713 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90818106 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90603012 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89942988 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89844514 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89547590 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88439536 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88285451 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87947944 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.84791503 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.84392373 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84284577 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82697755 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82617890 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.78959234 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78562914 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77221996 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77117323 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75833788 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.74721407 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72935504 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71639158 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70772902 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.70632459 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70230989 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.70111538 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69391448 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69082325 |
| 83 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68943974 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67664439 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67329269 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65735188 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65019842 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64216013 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63708877 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63619275 |
| 91 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62689119 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62510239 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59483150 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59434150 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59104201 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58412394 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58061649 |
| 98 | Cell cycle_Homo sapiens_hsa04110 | 0.57968654 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.57822911 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55024962 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.54884826 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.53749521 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.51974326 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51865873 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49760524 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48125855 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46820905 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43129281 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.41735725 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41701214 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.39712158 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38333120 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37296877 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36511275 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36056783 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35650606 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35499819 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35259241 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35102124 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34879410 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34643574 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.34292911 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33014133 |
| 124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32630129 |
| 125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.31941223 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30632585 |
| 127 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30271078 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29843218 |
| 129 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29090755 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28213500 |
| 131 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26181342 |
| 132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24965900 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24190882 |
| 134 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23583481 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23318454 |
| 136 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22644368 |
| 137 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22011501 |

